Tumor predisposition syndromes: The challenge of de novo mutations

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|65|3|pbc.26882-pbc.26882

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.65, Iss.3, 2018-03, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Early onset epileptic encephalopathy caused by de novo SCN8A mutations

By  

EPILEPSIA, Vol. 55, Iss. 7, 2014-07 ,pp. : 994-1000

John Wiley & Sons Inc

Access to resources Recommend Favorite

De novo KCNT1 mutations in early‐onset epileptic encephalopathy

By  

EPILEPSIA, Vol. 56, Iss. 9, 2015-09 ,pp. : e121-e128

John Wiley & Sons Inc

Access to resources Recommend Favorite

De novo Spinal Teratoma after Treatment of an Intracranial Germ Cell Tumor

By  

Pediatric Neurosurgery, Vol. 33, Iss. 5, 2001-01 ,pp. : 261-264

Karger

Access to resources Recommend Favorite

Micronuclei and Nuclear Abnormalities Observed in Erythroblasts in Myelodysplastic Syndromes and in de novo Acute Leukemia after Treatment

By  

Acta Haematologica, Vol. 101, Iss. 1, 1999-03 ,pp. : 32-40

Karger

Access to resources Recommend Favorite

TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 1, 2015-10 ,pp. : 91-99

John Wiley & Sons Inc

Access to resources Recommend Favorite